Less Ads, More Data, More Tools Register for FREE

Company Research

Filter Research Articles

Date TIDM Title Provider
16-Apr-25MTRODelivery on all targetsEdison
15-Apr-250RDBFirst patient dosed in iadademstat + ICI SCLC trialEdison
15-Apr-25NANOEncouraging commercial progressEdison
15-Apr-25Positive start to the yearEdison
15-Apr-25VP.Proving its quality and resilience once againEquity Development
15-Apr-25TAMRecord inflows (again), so impressive given marketsEquity Development
14-Apr-25Healthier optionsEquity Development
14-Apr-25ENSIAllenby Capital: EnSilica plc - UpdateAllenby Capital
14-Apr-25POLRMarkets hit AUM in Q4 of FY25, but net flows hold upEquity Development
11-Apr-25CCTAllenby Capital - Character Group - UpdateAllenby Capital
11-Apr-25DEVO2024 in line and 2025 to continue improvementsEdison
11-Apr-25OCNDisposal to generate surplus capitalEdison
10-Apr-25SARBroader pipeline, bigger milestonesEdison
10-Apr-25NXRA reassuringly solid FY25 performanceEquity Development
10-Apr-250RQJBroad pipeline to address neurological conditionsEdison
10-Apr-25SIGA.USDividends bring cheer amid market uncertaintyEdison
10-Apr-25CRDLPTC milestones crossedEdison
09-Apr-25BrainStorm Cell Therapeutics (BCLI) - Fundamentals Update 0904...ACF (Sponsored)
08-Apr-25BRAIProposed change in investment strategyEdison
08-Apr-25IPXOutlook hit by markets, but price fall looks extremeEquity Development
07-Apr-25ENSIAllenby Capital: EnSilica plc - Trading updateAllenby Capital
07-Apr-25CODEAllenby Capital TMT Update - 07.04.25 - SPSY.L, MWE.L, CLCO.L,...Allenby Capital
07-Apr-25FY24 net income growth of 20%Edison
04-Apr-251NB.MIStrategic alliance with GcoreEdison
04-Apr-25IMMX.USAll eyes on NEXICART-2Edison
03-Apr-250QOIPivotal evenamide trial loomsEdison
03-Apr-25OSE.PAPrimed for value appreciationEdison
03-Apr-25MOONFY25 update shows continued cash generationEdison
03-Apr-250R5WTurning the tankerEdison
02-Apr-25QEDMaking wavesEdison